People with a condition called wet age-related macular degeneration (AMD) often receive eye injections. These eye injections can help to improve vision and also stop the damage that causes vision to ...

CHICAGO — The number of injections required for the successful treatment of neovascular age-related macular degeneration could be reduced considerably with experimental therapies, new research shows.

In advanced dry disease, a key problem is failure of retinal pigment epithelium, often shortened to RPE. These cells help ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Patients with ...

Many frightening thoughts may go through your mind when you are first diagnosed with macular degeneration. Here is some basic information that can help to improve your understanding of this common eye ...

If you're apprehensive about getting an intravitreal injection for age-related macular degeneration (AMD), you're not alone. Ophthalmologist Monika Fleckenstein, MD, explains the procedure, how it can ...

An injection that helps to block the growth of abnormal blood vessels in the back of the eye in patients with wet age-related macular degeneration (AMD) is set to become available on the NHS in ...

An injection of stem cells into the eye may soon slow or reverse the effects of early-stage age-related macular degeneration, according to new research from scientists at Cedars-Sinai. Currently, ...

WAUSAU, Wis. (WSAW) - Geographic atrophy affects approximately one million people in the United States and is commonly associated with both dry and wet macular degeneration. Now a new treatment is ...

From left, Gregory S. Hageman, PhD, SCTM executive director; and Brandi L. Williams, PhD, chromosome 10 research leader and lead author. Research conducted at the Sharon Eccles Steele Center for ...